Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System

A Double-Blind Randomized Placebo-Controlled Pilot Study of Neuropsychiatric Adverse Events in Abstinent Smokers Treated with Varenicline or Placebo

(2011) Dahlia Garza et al.   BIOLOGICAL PSYCHIATRY

Mental health stability in veterans with posttraumatic stress disorder receiving varenicline

(2010) A. R. Campbell et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline

(2010) Serena Tonstad et al.   DRUG SAFETY

Confounding Control in Healthcare Database Research

(2010) M. Alan Brookhart et al.   MEDICAL CARE

Safety and Effectiveness of Varenicline in a Veteran Population with a High Prevalence of Mental Illness

(2009) Tara L Purvis et al.   ANNALS OF PHARMACOTHERAPY

Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study

(2009) Helene Faessel et al.   CLINICAL THERAPEUTICS

Mood, Side-effects and Smoking Outcomes Among Persons With and Without Probable Lifetime Depression Taking Varenicline

(2009) Jennifer B. McClure et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder

(2009) Robert C. Smith et al.   SCHIZOPHRENIA RESEARCH

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

(2007) John A. Stapleton et al.   ADDICTION